Status:
UNKNOWN
Clinical, Physiological and Prognostic Implication of Microvascular Status
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Ulsan University Hospital
Keimyung University
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
There are several physiologic parameters in evaluating cardiovascular disease. This study will reveal which parameter is the most proper value in predicting disease severity and risk factors of patien...
Detailed Description
Fractional Flow Reserve (FFR), index of microcirculatory resistance (IMR), and coronary flow reserve (CFR) will be measured in stable angina patients before coronary intervention. Relationship betwee...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Patients with stable angina
- FFR, IMR, CFR were measured before coronary intervention
Exclusion
- Patients who have severe side effects or contraindication to hyperemic agents (ex. adenosine)
- Patients with hemodynamic instability
- elevation of cardiac enzymes, evidence of acute MI, or a culprit vessel of acute coronary syndrome
Key Trial Info
Start Date :
April 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
1197 Patients enrolled
Trial Details
Trial ID
NCT02186093
Start Date
April 1 2009
End Date
November 1 2020
Last Update
November 27 2017
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Keimyung University Dongsan medical center
Daegu, South Korea
2
Inje University Ilsan Paik Hospital
Goyang, South Korea
3
Seoul National University Hospital
Seoul, South Korea, 110-744
4
Samsung Medical Center
Seoul, South Korea